Northwestern University Feinberg School of Medicine
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Lou and Jean Malnati Brain Tumor Institute
Skip to main content

Inhibiting Autophagy to Increase the Anti-Tumor Activity of Conventional Therapy

Authophagy is a process by which tumor cells use their internal macromolecules as a source of energy when external nutrients are scarce or when exposed to harsh environmental conditions, such as those created by the administration of chemo- and radiation therapy. Northwestern investigators have discovered a novel signaling pathway that is important for authophagy activation. An inhibitor of a key signaling mediator in this pathway has likewise been identified and is currently being tested in animal model studies for its ability to increase the anti-tumor activity of radiation and the chemotherapeutic temozolomide, each of which is routinely used in treating glioblastoma patients.


Back to top